Recombinant AAT-Fc fusion protein INBRX-101 achieves normal serum AAT levels in patients with alpha-1 antitrypsin deficiency (AATD)
A. Veale (Auckland, New Zealand), H. Farah (Hannibal, United States), R. Mahadeva (Cambridge, United Kingdom), M. Baker (Auckland, New Zealand), B. Kuhn (Sacramento, United States), A. Cole (Christchurch, New Zealand), C. Chang (Hamilton, New Zealand), C. Brown (Indianapolis, United States), M. Campos (Miami, United States), J. Kalabus (La Jolla, United States), T. Boyea (La Jolla, United States), C. Veldstra (La Jolla, United States), V. Andrianov (La Jolla, United States), S. Bhagwat (La Jolla, United States), B. Eckelman (La Jolla, United States), J. Loscano (Gainesville, United States), M. Brantly (Gainesville, United States)
Source: International Congress 2022 – COPD clinical studies and exacerbations
Session: COPD clinical studies and exacerbations
Session type: Thematic Poster
Number: 3615
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Veale (Auckland, New Zealand), H. Farah (Hannibal, United States), R. Mahadeva (Cambridge, United Kingdom), M. Baker (Auckland, New Zealand), B. Kuhn (Sacramento, United States), A. Cole (Christchurch, New Zealand), C. Chang (Hamilton, New Zealand), C. Brown (Indianapolis, United States), M. Campos (Miami, United States), J. Kalabus (La Jolla, United States), T. Boyea (La Jolla, United States), C. Veldstra (La Jolla, United States), V. Andrianov (La Jolla, United States), S. Bhagwat (La Jolla, United States), B. Eckelman (La Jolla, United States), J. Loscano (Gainesville, United States), M. Brantly (Gainesville, United States). Recombinant AAT-Fc fusion protein INBRX-101 achieves normal serum AAT levels in patients with alpha-1 antitrypsin deficiency (AATD). 3615
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|